UTA NURS 5334 QUIZ 2 STUDYGUIDE QUESTIONS AND CORRECT ANSWERS
Question:
1. UTA NURS 5334 QUIZ 2
Answer:
Exam Coverage Exam coverage for UTA NURS 5334 Quiz 2 at University of Texas at Arlington
includes advanced nursing concepts typically covered in the second portion of the course. It
focuses on evidence-based practice, research methodologies, data interpretation, and
application of research findings to clinical decision-making. The quiz also evaluates
understanding of research design, statistical concepts, literature appraisal, and ethical
considerations in nursing research. Emphasis is placed on critical thinking, analyzing research
studies, applying evidence to improve patient outcomes, and integrating scholarly evidence into
advanced nursing practice. >z =Ø ’
Question:
2. Older adults
Answer:
Thinner skin higher risk of steroid-induced atrophy.
Question:
3. Hormonal therapy (OCPs)
Answer:
May be used in women for acne.
Question:
4. Isotretinoin, acitretin, and finasteride
Answer:
Avoid in pregnancy due to teratogenic effects.
Question:
5. Infants/children
Answer:
Use low-potency steroids sparingly; avoid calcineurin inhibitors <3 yrs.
Question:
6. Topical metronidazole and azelaic acid
Answer:
Safe in pregnancy.
Question:
7. Terbinafine
Answer:
Avoid in breastfeeding as it accumulates in milk.
,Question:
8. Psoriasis treatment
Answer:
Start with cost-effective topicals (steroids, vitamin D analogues); escalate to systemic therapy if
>5% BSA.
Question:
9. Acne first-line treatments
Answer:
Benzoyl peroxide and retinoids are inexpensive and effective.
Question:
10. Isotretinoin
Answer:
Requires monitoring and registration.
Question:
11. Eczema treatment
Answer:
Emollients and steroids are first-line; calcineurin inhibitors for steroid-sparing use.
Question:
12. Topical steroids monitoring
Answer:
Monitor for skin atrophy, striae, hypopigmentation.
Question:
13. Isotretinoin monitoring
Answer:
Monitor liver function, lipids, pregnancy tests.
Question:
14. Antifungals monitoring
Answer:
Monitor LFTs for terbinafine and azoles.
Question:
15. Methotrexate monitoring (psoriasis)
Answer:
Monitor CBC, LFTs, renal function.
Question:
16. Infants/Children drug precautions
,Answer:
Avoid systemic steroids; cautious with high-potency topicals.
Question:
17. Pregnant women drug precautions
Answer:
Avoid teratogenic drugs (isotretinoin, acitretin, finasteride, methoxsalen).
Question:
18. Older adults drug precautions
Answer:
Higher risk of adverse skin thinning with steroids.
Question:
19. Transgender patients
Answer:
Consider hormonal therapies (OCPs, spironolactone) with attention to interactions. eSPF
Question:
20. Sunscreen application
Answer:
Apply 3 tbsp every 2 hrs, broad spectrum 30.
Question:
21. Steroid use
Answer:
Apply thin layer, lowest potency, avoid face/perineum unless directed.
Question:
22. Acne medications
Answer:
Retinoids may worsen acne before improving; isotretinoin requires iPledge compliance.
Question:
23. Oral terbinafine for onychomycosis
Answer:
Must be taken for months. ‘
Question:
24. Griseofulvin drug-food interaction
Answer:
With fatty meals absorption.
Question:
, 25. Legal prescriptions
Answer:
Follow state-specific requirements for APRN prescriptive authority.
Question:
26. Generic names in prescriptions
Answer:
Use when possible; include strength, dosage, route, frequency, and duration.
Question:
27. Controlled/teratogenic medications
Answer:
Ensure they follow federal monitoring programs.
Question:
28. Epidermis
Answer:
Protective layer, stratum corneum with lipids/keratin.
Question:
29. Dermis
Answer:
Connective tissue, sweat glands, sebaceous glands, hair follicles, vessels.
Question:
30. Ointment
Answer:
Oil-based, occlusive, best for dry, scaly lesions.
Question:
31. Cream
Answer:
Water-based, less greasy, for moist/weeping lesions.
Question:
32. Lotion/Solution/Gel/Foam
Answer:
Useful for hairy areas and widespread application.
Question:
33. Retinoids
Answer:
Comedolytic, anti-inflammatory agents used in acne treatment.
Question:
1. UTA NURS 5334 QUIZ 2
Answer:
Exam Coverage Exam coverage for UTA NURS 5334 Quiz 2 at University of Texas at Arlington
includes advanced nursing concepts typically covered in the second portion of the course. It
focuses on evidence-based practice, research methodologies, data interpretation, and
application of research findings to clinical decision-making. The quiz also evaluates
understanding of research design, statistical concepts, literature appraisal, and ethical
considerations in nursing research. Emphasis is placed on critical thinking, analyzing research
studies, applying evidence to improve patient outcomes, and integrating scholarly evidence into
advanced nursing practice. >z =Ø ’
Question:
2. Older adults
Answer:
Thinner skin higher risk of steroid-induced atrophy.
Question:
3. Hormonal therapy (OCPs)
Answer:
May be used in women for acne.
Question:
4. Isotretinoin, acitretin, and finasteride
Answer:
Avoid in pregnancy due to teratogenic effects.
Question:
5. Infants/children
Answer:
Use low-potency steroids sparingly; avoid calcineurin inhibitors <3 yrs.
Question:
6. Topical metronidazole and azelaic acid
Answer:
Safe in pregnancy.
Question:
7. Terbinafine
Answer:
Avoid in breastfeeding as it accumulates in milk.
,Question:
8. Psoriasis treatment
Answer:
Start with cost-effective topicals (steroids, vitamin D analogues); escalate to systemic therapy if
>5% BSA.
Question:
9. Acne first-line treatments
Answer:
Benzoyl peroxide and retinoids are inexpensive and effective.
Question:
10. Isotretinoin
Answer:
Requires monitoring and registration.
Question:
11. Eczema treatment
Answer:
Emollients and steroids are first-line; calcineurin inhibitors for steroid-sparing use.
Question:
12. Topical steroids monitoring
Answer:
Monitor for skin atrophy, striae, hypopigmentation.
Question:
13. Isotretinoin monitoring
Answer:
Monitor liver function, lipids, pregnancy tests.
Question:
14. Antifungals monitoring
Answer:
Monitor LFTs for terbinafine and azoles.
Question:
15. Methotrexate monitoring (psoriasis)
Answer:
Monitor CBC, LFTs, renal function.
Question:
16. Infants/Children drug precautions
,Answer:
Avoid systemic steroids; cautious with high-potency topicals.
Question:
17. Pregnant women drug precautions
Answer:
Avoid teratogenic drugs (isotretinoin, acitretin, finasteride, methoxsalen).
Question:
18. Older adults drug precautions
Answer:
Higher risk of adverse skin thinning with steroids.
Question:
19. Transgender patients
Answer:
Consider hormonal therapies (OCPs, spironolactone) with attention to interactions. eSPF
Question:
20. Sunscreen application
Answer:
Apply 3 tbsp every 2 hrs, broad spectrum 30.
Question:
21. Steroid use
Answer:
Apply thin layer, lowest potency, avoid face/perineum unless directed.
Question:
22. Acne medications
Answer:
Retinoids may worsen acne before improving; isotretinoin requires iPledge compliance.
Question:
23. Oral terbinafine for onychomycosis
Answer:
Must be taken for months. ‘
Question:
24. Griseofulvin drug-food interaction
Answer:
With fatty meals absorption.
Question:
, 25. Legal prescriptions
Answer:
Follow state-specific requirements for APRN prescriptive authority.
Question:
26. Generic names in prescriptions
Answer:
Use when possible; include strength, dosage, route, frequency, and duration.
Question:
27. Controlled/teratogenic medications
Answer:
Ensure they follow federal monitoring programs.
Question:
28. Epidermis
Answer:
Protective layer, stratum corneum with lipids/keratin.
Question:
29. Dermis
Answer:
Connective tissue, sweat glands, sebaceous glands, hair follicles, vessels.
Question:
30. Ointment
Answer:
Oil-based, occlusive, best for dry, scaly lesions.
Question:
31. Cream
Answer:
Water-based, less greasy, for moist/weeping lesions.
Question:
32. Lotion/Solution/Gel/Foam
Answer:
Useful for hairy areas and widespread application.
Question:
33. Retinoids
Answer:
Comedolytic, anti-inflammatory agents used in acne treatment.
